Safety and diagnostic accuracy of dipyridamole-thallium imaging in the elderly
JY Lam,
BR Chaitman,
M Glaenzer,
S Byers,
J Fite,
Y Shah,
H Goodgold,
and
L Samuels
Department of Medicine, St. Louis, University School of Medicine, Missouri 63104.
The noninvasive diagnosis of coronary artery disease in the elderly can occasionally be difficult. Intravenous dipyridamole-thallium imaging is a potentially useful diagnostic test to determine presence and severity of coronary disease; however, the safety of the procedure has not been determined in an older population. The side effect profile and frequency of severe ischemic responses after 0.56 mg/kg of intravenous dipyridamole were compared in 101 patients greater than or equal to 70 years old and 236 patients less than 70 years old. There were no side effects in 64% and 62% of patients greater than or equal to 70 and less than 70 years old, respectively (p = NS). Among the 337 patients tested, there were no complications of myocardial infarction or death. The most common cardiac side effect was chest pain, which occurred in 21 (21%) of the 101 patients aged greater than or equal to 70 years and in 64 (27%) of the 236 patients less than 70 years (p = NS). Aminophylline was required to reverse cardiac or noncardiac side effects in 15 (15%) and 36 (15%) of the patients greater than or equal to 70 and less than 70 years old, respectively (p = NS). A severe ischemic response occurred in 2% and 2.5% of patients greater than or equal to 70 and less than 70 years old, respectively (p = NS). The sensitivity of intravenous dipyridamole-thallium imaging for obstructive coronary artery disease was 86% (25 of 29) and 83% (68 of 82) in older and younger patients, respectively (p = NS); the specificity was 75% (6 of 8) and 70% (16 of 23), respectively (p = NS). Thus, intravenous dipyridamole-thallium imaging is a safe noninvasive method for assessment of older patients with obstructive coronary disease; its side effect profile and diagnostic accuracy are similar to those seen in younger patients. The technique is associated with severe ischemic responses in only a small minority of patients.
This article has been cited by other articles:
|
|
|
|
 
A.M. Cicatiello, P. Landino, P. Simonelli, L. Del Mastro, P. Ferrara, A. Cioppa, and F. Ciaburri
Safety of Echo-Dipyridamole Test in Elderly Patients with Coronary Artery Disease
Angiology,
April 1, 1995;
46(4):
321 - 326.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. Le Feuvre, J. L. Georges, J. P. Metzger, D. Etienne, P. Albarede, P. de Vernejoul, and A. Vacheron
Usefulness of Radionuclide Ventriculography During Transesophageal Atrial Pacing in the Diagnosis of Coronary Artery Disease
Angiology,
July 1, 1994;
45(7):
621 - 628.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T. Konishi, T. Koyama, T. Aoki, Y. Futagami, and T. Nakano
Dipyridamole Radionuclide Ventriculography in Patients with Coronary Artery Disease: Comparison with Ergometer Exercise
Angiology,
July 1, 1990;
41(7):
518 - 524.
[Abstract]
[PDF]
|
|
|
|
|
|
|
DIPYRIDAMOLE-THALLIUM TEST IS SAFE FOR OLD AND YOUNG
Journal Watch (General),
March 11, 1988;
1988(311):
4 - 4.
[Full Text]
|
|
|
|
